aluates Reports

$ 0.0

Automative

Global Rituxan (Rituximab) and Biosimilar Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-2Z14941

Global Rituxan Rituximab and Biosimilar Market Research Report 2023

BUY CHAPTERS

Global Rituxan (Rituximab) and Biosimilar Market Research Report 2025

Code: QYRE-Auto-2Z14941

Report

May 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

TEVA

Amgen Inc

Pfizer Inc

Rituxan (Rituximab) and Biosimilar Market Size

The global market for Rituxan (Rituximab) and Biosimilar was valued at US$ 4453 million in the year 2024 and is projected to reach a revised size of US$ 5646 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Rituxan (Rituximab) and Biosimilar Market

RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin"s Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin"s Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines.

North American market for Rituxan (Rituximab) and Biosimilar is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Rituxan (Rituximab) and Biosimilar is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Rituxan (Rituximab) and Biosimilar include Roche, Teva, Pfizer, Amgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rituxan (Rituximab) and Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituxan (Rituximab) and Biosimilar.

The Rituxan (Rituximab) and Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rituxan (Rituximab) and Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rituxan (Rituximab) and Biosimilar manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rituxan (Rituximab) and Biosimilar Market Report

Report Metric	Details
Report Name	Rituxan (Rituximab) and Biosimilar Market
Accounted market size in year	US$ 4453 million
Forecasted market size in 2031	US$ 5646 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Brand Biosimilar
Segment by Application	Child Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Teva, Pfizer, Amgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rituxan (Rituximab) and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rituxan (Rituximab) and Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Rituxan (Rituximab) and Biosimilar Market growing?

Ans: The Rituxan (Rituximab) and Biosimilar Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Rituxan (Rituximab) and Biosimilar Market size in 2031?

Ans: The Rituxan (Rituximab) and Biosimilar Market size in 2031 will be US$ 5646 million.

Who are the main players in the Rituxan (Rituximab) and Biosimilar Market report?

Ans: The main players in the Rituxan (Rituximab) and Biosimilar Market are Roche, Teva, Pfizer, Amgen

What are the Application segmentation covered in the Rituxan (Rituximab) and Biosimilar Market report?

Ans: The Applications covered in the Rituxan (Rituximab) and Biosimilar Market report are Child, Adult

What are the Type segmentation covered in the Rituxan (Rituximab) and Biosimilar Market report?

Ans: The Types covered in the Rituxan (Rituximab) and Biosimilar Market report are Brand, Biosimilar

Recommended Reports

Lymphoma Treatments

Rituximab Biosimilars

Cancer Drug Markets

1 Rituxan (Rituximab) and Biosimilar Market Overview

1.1 Product Definition

1.2 Rituxan (Rituximab) and Biosimilar by Type

1.2.1 Global Rituxan (Rituximab) and Biosimilar Market Value Comparison by Type (2024 VS 2031)

1.2.2 Brand

1.2.3 Biosimilar

1.3 Rituxan (Rituximab) and Biosimilar by Application

1.3.1 Global Rituxan (Rituximab) and Biosimilar Market Value by Application (2024 VS 2031)

1.3.2 Child

1.3.3 Adult

1.4 Global Rituxan (Rituximab) and Biosimilar Market Size Estimates and Forecasts

1.4.1 Global Rituxan (Rituximab) and Biosimilar Revenue 2020-2031

1.4.2 Global Rituxan (Rituximab) and Biosimilar Sales 2020-2031

1.4.3 Global Rituxan (Rituximab) and Biosimilar Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Rituxan (Rituximab) and Biosimilar Market Competition by Manufacturers

2.1 Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Manufacturers (2020-2025)

2.2 Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Rituxan (Rituximab) and Biosimilar Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Rituxan (Rituximab) and Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Product Type & Application

2.7 Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Date of Enter into This Industry

2.8 Global Rituxan (Rituximab) and Biosimilar Market Competitive Situation and Trends

2.8.1 Global Rituxan (Rituximab) and Biosimilar Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Rituxan (Rituximab) and Biosimilar Players Market Share by Revenue

2.8.3 Global Rituxan (Rituximab) and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rituxan (Rituximab) and Biosimilar Market Scenario by Region

3.1 Global Rituxan (Rituximab) and Biosimilar Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Rituxan (Rituximab) and Biosimilar Sales by Region: 2020-2031

3.2.1 Global Rituxan (Rituximab) and Biosimilar Sales by Region: 2020-2025

3.2.2 Global Rituxan (Rituximab) and Biosimilar Sales by Region: 2026-2031

3.3 Global Rituxan (Rituximab) and Biosimilar Revenue by Region: 2020-2031

3.3.1 Global Rituxan (Rituximab) and Biosimilar Revenue by Region: 2020-2025

3.3.2 Global Rituxan (Rituximab) and Biosimilar Revenue by Region: 2026-2031

3.4 North America Rituxan (Rituximab) and Biosimilar Market Facts & Figures by Country

3.4.1 North America Rituxan (Rituximab) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2031)

3.4.3 North America Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rituxan (Rituximab) and Biosimilar Market Facts & Figures by Country

3.5.1 Europe Rituxan (Rituximab) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2031)

3.5.3 Europe Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rituxan (Rituximab) and Biosimilar Market Facts & Figures by Region

3.6.1 Asia Pacific Rituxan (Rituximab) and Biosimilar Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Rituxan (Rituximab) and Biosimilar Sales by Region (2020-2031)

3.6.3 Asia Pacific Rituxan (Rituximab) and Biosimilar Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Rituxan (Rituximab) and Biosimilar Market Facts & Figures by Country

3.7.1 Latin America Rituxan (Rituximab) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2031)

3.7.3 Latin America Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rituxan (Rituximab) and Biosimilar Market Facts & Figures by Country

3.8.1 Middle East and Africa Rituxan (Rituximab) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2031)

3.8.3 Middle East and Africa Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rituxan (Rituximab) and Biosimilar Sales by Type (2020-2031)

4.1.1 Global Rituxan (Rituximab) and Biosimilar Sales by Type (2020-2025)

4.1.2 Global Rituxan (Rituximab) and Biosimilar Sales by Type (2026-2031)

4.1.3 Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Type (2020-2031)

4.2 Global Rituxan (Rituximab) and Biosimilar Revenue by Type (2020-2031)

4.2.1 Global Rituxan (Rituximab) and Biosimilar Revenue by Type (2020-2025)

4.2.2 Global Rituxan (Rituximab) and Biosimilar Revenue by Type (2026-2031)

4.2.3 Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Type (2020-2031)

4.3 Global Rituxan (Rituximab) and Biosimilar Price by Type (2020-2031)

5 Segment by Application

5.1 Global Rituxan (Rituximab) and Biosimilar Sales by Application (2020-2031)

5.1.1 Global Rituxan (Rituximab) and Biosimilar Sales by Application (2020-2025)

5.1.2 Global Rituxan (Rituximab) and Biosimilar Sales by Application (2026-2031)

5.1.3 Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Application (2020-2031)

5.2 Global Rituxan (Rituximab) and Biosimilar Revenue by Application (2020-2031)

5.2.1 Global Rituxan (Rituximab) and Biosimilar Revenue by Application (2020-2025)

5.2.2 Global Rituxan (Rituximab) and Biosimilar Revenue by Application (2026-2031)

5.2.3 Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Application (2020-2031)

5.3 Global Rituxan (Rituximab) and Biosimilar Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Rituxan (Rituximab) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Rituxan (Rituximab) and Biosimilar Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Teva

6.2.1 Teva Company Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Rituxan (Rituximab) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Teva Rituxan (Rituximab) and Biosimilar Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Rituxan (Rituximab) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer Rituxan (Rituximab) and Biosimilar Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Amgen

6.4.1 Amgen Company Information

6.4.2 Amgen Description and Business Overview

6.4.3 Amgen Rituxan (Rituximab) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Amgen Rituxan (Rituximab) and Biosimilar Product Portfolio

6.4.5 Amgen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rituxan (Rituximab) and Biosimilar Industry Chain Analysis

7.2 Rituxan (Rituximab) and Biosimilar Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rituxan (Rituximab) and Biosimilar Production Mode & Process Analysis

7.4 Rituxan (Rituximab) and Biosimilar Sales and Marketing

7.4.1 Rituxan (Rituximab) and Biosimilar Sales Channels

7.4.2 Rituxan (Rituximab) and Biosimilar Distributors

7.5 Rituxan (Rituximab) and Biosimilar Customer Analysis

8 Rituxan (Rituximab) and Biosimilar Market Dynamics

8.1 Rituxan (Rituximab) and Biosimilar Industry Trends

8.2 Rituxan (Rituximab) and Biosimilar Market Drivers

8.3 Rituxan (Rituximab) and Biosimilar Market Challenges

8.4 Rituxan (Rituximab) and Biosimilar Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Roche

TEVA

Amgen Inc

Pfizer Inc

List of Tables

Table 1. Global Rituxan (Rituximab) and Biosimilar Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Rituxan (Rituximab) and Biosimilar Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Rituxan (Rituximab) and Biosimilar Market Competitive Situation by Manufacturers in 2024

Table 4. Global Rituxan (Rituximab) and Biosimilar Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Rituxan (Rituximab) and Biosimilar Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Rituxan (Rituximab) and Biosimilar Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Rituxan (Rituximab) and Biosimilar Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Rituxan (Rituximab) and Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Product Type & Application

Table 12. Global Key Manufacturers of Rituxan (Rituximab) and Biosimilar, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rituxan (Rituximab) and Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituxan (Rituximab) and Biosimilar as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rituxan (Rituximab) and Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Rituxan (Rituximab) and Biosimilar Sales by Region (2020-2025) & (K Units)

Table 18. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Region (2020-2025)

Table 19. Global Rituxan (Rituximab) and Biosimilar Sales by Region (2026-2031) & (K Units)

Table 20. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Region (2026-2031)

Table 21. Global Rituxan (Rituximab) and Biosimilar Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Region (2020-2025)

Table 23. Global Rituxan (Rituximab) and Biosimilar Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Region (2026-2031)

Table 25. North America Rituxan (Rituximab) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2025) & (K Units)

Table 27. North America Rituxan (Rituximab) and Biosimilar Sales by Country (2026-2031) & (K Units)

Table 28. North America Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Rituxan (Rituximab) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Rituxan (Rituximab) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2025) & (K Units)

Table 32. Europe Rituxan (Rituximab) and Biosimilar Sales by Country (2026-2031) & (K Units)

Table 33. Europe Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Rituxan (Rituximab) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Rituxan (Rituximab) and Biosimilar Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Rituxan (Rituximab) and Biosimilar Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Rituxan (Rituximab) and Biosimilar Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Rituxan (Rituximab) and Biosimilar Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Rituxan (Rituximab) and Biosimilar Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rituxan (Rituximab) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Rituxan (Rituximab) and Biosimilar Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Rituxan (Rituximab) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Rituxan (Rituximab) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Rituxan (Rituximab) and Biosimilar Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Rituxan (Rituximab) and Biosimilar Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Rituxan (Rituximab) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Rituxan (Rituximab) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Rituxan (Rituximab) and Biosimilar Sales (K Units) by Type (2020-2025)

Table 51. Global Rituxan (Rituximab) and Biosimilar Sales (K Units) by Type (2026-2031)

Table 52. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Type (2020-2025)

Table 53. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Type (2026-2031)

Table 54. Global Rituxan (Rituximab) and Biosimilar Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Rituxan (Rituximab) and Biosimilar Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Type (2020-2025)

Table 57. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Type (2026-2031)

Table 58. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Type (2020-2025)

Table 59. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Type (2026-2031)

Table 60. Global Rituxan (Rituximab) and Biosimilar Sales (K Units) by Application (2020-2025)

Table 61. Global Rituxan (Rituximab) and Biosimilar Sales (K Units) by Application (2026-2031)

Table 62. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Application (2020-2025)

Table 63. Global Rituxan (Rituximab) and Biosimilar Sales Market Share by Application (2026-2031)

Table 64. Global Rituxan (Rituximab) and Biosimilar Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Rituxan (Rituximab) and Biosimilar Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Application (2020-2025)

Table 67. Global Rituxan (Rituximab) and Biosimilar Revenue Market Share by Application (2026-2031)

Table 68. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Application (2020-2025)

Table 69. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Application (2026-2031)

Table 70. Roche Company Information

Table 71. Roche Description and Business Overview

Table 72. Roche Rituxan (Rituximab) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Roche Rituxan (Rituximab) and Biosimilar Product

Table 74. Roche Recent Developments/Updates

Table 75. Teva Company Information

Table 76. Teva Description and Business Overview

Table 77. Teva Rituxan (Rituximab) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Teva Rituxan (Rituximab) and Biosimilar Product

Table 79. Teva Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Rituxan (Rituximab) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Pfizer Rituxan (Rituximab) and Biosimilar Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Amgen Company Information

Table 86. Amgen Description and Business Overview

Table 87. Amgen Rituxan (Rituximab) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Amgen Rituxan (Rituximab) and Biosimilar Product

Table 89. Amgen Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Rituxan (Rituximab) and Biosimilar Distributors List

Table 93. Rituxan (Rituximab) and Biosimilar Customers List

Table 94. Rituxan (Rituximab) and Biosimilar Market Trends

Table 95. Rituxan (Rituximab) and Biosimilar Market Drivers

Table 96. Rituxan (Rituximab) and Biosimilar Market Challenges

Table 97. Rituxan (Rituximab) and Biosimilar Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rituxan (Rituximab) and Biosimilar

Figure 2. Global Rituxan (Rituximab) and Biosimilar Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rituxan (Rituximab) and Biosimilar Market Share by Type: 2024 & 2031

Figure 4. Brand Product Picture

Figure 5. Biosimilar Product Picture

Figure 6. Global Rituxan (Rituximab) and Biosimilar Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Rituxan (Rituximab) and Biosimilar Market Share by Application: 2024 & 2031

Figure 8. Child

Figure 9. Adult

Figure 10. Global Rituxan (Rituximab) and Biosimilar Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Rituxan (Rituximab) and Biosimilar Market Size (2020-2031) & (US$ Million)

Figure 12. Global Rituxan (Rituximab) and Biosimilar Sales (2020-2031) & (K Units)

Figure 13. Global Rituxan (Rituximab) and Biosimilar Average Price (US$/Unit) & (2020-2031)

Figure 14. Rituxan (Rituximab) and Biosimilar Report Years Considered

Figure 15. Rituxan (Rituximab) and Biosimilar Sales Share by Manufacturers in 2024

Figure 16. Global Rituxan (Rituximab) and Biosimilar Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Rituxan (Rituximab) and Biosimilar Players: Market Share by Revenue in Rituxan (Rituximab) and Biosimilar in 2024

Figure 18. Rituxan (Rituximab) and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Rituxan (Rituximab) and Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Rituxan (Rituximab) and Biosimilar Sales Market Share by Country (2020-2031)

Figure 21. North America Rituxan (Rituximab) and Biosimilar Revenue Market Share by Country (2020-2031)

Figure 22. United States Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Rituxan (Rituximab) and Biosimilar Sales Market Share by Country (2020-2031)

Figure 25. Europe Rituxan (Rituximab) and Biosimilar Revenue Market Share by Country (2020-2031)

Figure 26. Germany Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Rituxan (Rituximab) and Biosimilar Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Rituxan (Rituximab) and Biosimilar Revenue Market Share by Region (2020-2031)

Figure 33. China Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Rituxan (Rituximab) and Biosimilar Sales Market Share by Country (2020-2031)

Figure 41. Latin America Rituxan (Rituximab) and Biosimilar Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Rituxan (Rituximab) and Biosimilar Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Rituxan (Rituximab) and Biosimilar Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Rituxan (Rituximab) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Rituxan (Rituximab) and Biosimilar by Type (2020-2031)

Figure 51. Global Revenue Market Share of Rituxan (Rituximab) and Biosimilar by Type (2020-2031)

Figure 52. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Rituxan (Rituximab) and Biosimilar by Application (2020-2031)

Figure 54. Global Revenue Market Share of Rituxan (Rituximab) and Biosimilar by Application (2020-2031)

Figure 55. Global Rituxan (Rituximab) and Biosimilar Price (US$/Unit) by Application (2020-2031)

Figure 56. Rituxan (Rituximab) and Biosimilar Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Rituxan rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rituximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rituxan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rituximab Biosimilars Market Research Report 2025

Rituximab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Rituximab Injection Market Research Report 2024

Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Avastin Bevacizumab Biosimilars Market Research Report 2024

Bevacizumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Broluzumab Biosimilars Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions